Imaging Features of Multiple Myeloma Extramedullary Lesions in the Liver with 18F-FDG PET/CT, Contrast-Enhanced CT and MRI.
Dimitris PapamichailRobert HogHartmut GoldschmidtAntonia Dimitrakopoulou-StraussPublished in: Diagnostics (Basel, Switzerland) (2019)
Ηepatic involvement in multiple myeloma is not common; nevertheless, it is associated with poorer outcome. Heterogeneous features have been described in few published reports so far. We present the imaging findings of PET/CT in comparison to those of MRI for two multiple myeloma (MM) patients, one with a liver lesion suspicious for myeloma metastasis on PET and one with multiple liver lesions suspicious for myeloma metastases on MRΙ. The subsequent ultrasound-guided needle biopsies confirmed the extramedullary spread of the disease in both patients. The first case exhibited a match in both functional imaging modalities (PET and MRI) but a mismatch of intense metabolic activity on 18F-fluorodeoxyglucose (18F-FDG) PET/CT and iso-attenuating liver parenchyma on contrast-enhanced CT. The second case showed a mismatch of signal elevation persistence on diffusion-weighted imaging (DWI) and physiologic 18F-FDG distribution in the liver parenchyma. These cases present different imaging features in MM lesions of the liver using PET/CT and MRI, reflecting the high disease heterogeneity in patients with MM and demonstrating that the use of both PET/CT and MRI may offer complementary information.
Keyphrases
- contrast enhanced
- pet ct
- diffusion weighted imaging
- diffusion weighted
- magnetic resonance imaging
- multiple myeloma
- computed tomography
- positron emission tomography
- magnetic resonance
- newly diagnosed
- end stage renal disease
- ultrasound guided
- high resolution
- ejection fraction
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- emergency department
- social media
- patient reported outcomes
- patient reported
- pet imaging